Tonix Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.76-$72 |
Market Cap | $234.7M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $9.8M |
Revenue Growth (YoY) | -9.5% |
Gross Profit (12 Mos) | $2.8M |
Diluted EPS | $2,614.12 |
News
See moreYahoo Finance • 6 days ago
Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive Disorder
Yahoo Finance • 7 days ago
Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
Yahoo Finance • 18 days ago
Mpox in Africa is no longer a global health emergency, WHO chief says
Yahoo Finance • last month
SA analyst upgrades/downgrades: HD, AAPL, TMUS, TNXP
About
CEO | Dr. Seth Lederman M.D. |
CFO | Mr. Bradley Saenger CPA |
Address | 26 Main Street, Chatham, NJ, United States, 07928 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |
